0141 352 98 55

25 Blythswood Square, Glasgow, G2 4BL

Appointment of Head of Data Quality
April 14, 2021
Donna Lawson

Data insights firm Talking Medicines, specialist in ‘social intelligence’ for the pharmaceutical industry, has appointed Donna Lawson to the position of Head of Data Quality. A particularly good fit for the role, Donna brings with her over two decades’ experience within clinical data management.

Donna’s appointment follows a period of substantial growth for the Glasgow-based company, with £1.1 million funding secured in November 2020 and three senior appointments in 2021 so far. Talking Medicines continues to develop and scale up its AI-based data technology platform, PatientMetRx, which is designed to distil complex data from a range of sources and provide meaningful insights for the pharmaceutical sector.

Donna joins Talking Medicines from IQVIA Biotech where she was Director of Data Management and was previously Global Head of UK Data Management at ClinTec International. Areas of specialism have included data quality, overseeing the use of client data, strategic planning and implementing data protection and quality improvement.

Talking Medicines CEO, Jo Halliday, said: “We’re exceptionally pleased to be welcoming Donna to the team and we’ve been impressed with her passion for data, particularly the use of data within the pharmaceutical industry. Donna has managed many project teams from database development/implementation to final submissions to regulatory authorities and will play an important part in ensuring the data quality standard of our PatientMetRx product.

“High quality, reliable data is absolutely critical to what we do. Donna’s experience will be invaluable as we continue to develop our AI platforms and embark on our next stage of growth.”

Donna Lawson said: “The work that Talking Medicines is doing in making sense of complex data for the pharmaceutical industry is at the forefront of data technology and I’m excited to be joining the team and being part of the company’s journey.”

About Talking Medicines 

Talking Medicines is the world’s first social intelligence company designed specifically for the pharmaceutical industry. By structuring and translating the patient’s voice on social media into actionable intelligence, it helps pharma deliver a greater return on investment for marketing, and better health outcomes for patients.

 

Recent Blogs

How the pandemic is impacting the way drugs are launched

How the pandemic is impacting the way drugs are launched

Though we don’t yet know to what extent, it is clear the pandemic has had and will continue to have an impact on the pharmaceutical industry and how new drugs are launched. From a pharma perspective, not being able to communicate with healthcare professionals in their...

Softening of public attitude towards COVID-19 vaccines

Softening of public attitude towards COVID-19 vaccines

In December Talking Medicines carried out two ‘pulse’ surveys of the UK public to gauge opinion towards COVID-19 vaccines and found that over the month, attitude had softened, with more people intending to take the vaccine once it becomes available to them. The...

Growing the Product Tech Team

Growing the Product Tech Team

We are so pleased to welcome four talented individuals to our team. Through their knowledge and experience, we look forward to accelerating our AI driven data insights product aligned to the needs of our commercial marketing pharmaceutical customers. Stewart McKee -...